Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Churchill Downs, Inc. (CHDN), Zebra Technologies Corp. (ZBRA): Clovis Capital’s Top Q2 Picks Coming Off Big Q1

Page 1 of 2

Scott Scher and Michael Prober‘s Clovis Capital Management has joined the ranks of hedge funds which have disclosed their equity portfolios for the reporting period of March 31, recently filing its 13F with the SEC for the period in question. Clovis Capital focuses on small- to mid-cap companies with a market capitalization of between $1 billion and $20 billion, in order to deliver attractive risk-adjusted returns. The philosophy behind its investments is to seek less efficient segments of the market in order to capture the best alpha. The fund managers believe in conducting original research and thinking contrarily to the consensus. The market value of the fund’s equity portfolio stood at $355 million at the end of March. The finance sector’s contribution of 49% to the above value was by far the highest of any sector. It was followed by the technology and industrial sectors, each contributing another 13%. The top holdings were comprised of Colony Capital Inc (NYSE:CLNY), Churchill Downs, Inc. (NASDAQ:CHDN), DigitalGlobe Inc (NYSE:DGI), and Zebra Technologies Corp. (NASDAQ:ZBRA).


Fer Gregory/

As far as the importance of tracking hedge funds is concerned, we discovered through our research that a portfolio of the 15 most popular small-cap picks of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month between 1999 and 2012. On the other hand the most popular large-cap picks of hedge funds under-performed the same index by seven basis points per month during the same period. In forward tests from August 2012 through March 2015, these top 15 small-cap stocks beat the market by a hefty 79.4 percentage points (read the details here). Hence a retail investor needs to isolate himself from the herd of investors chasing large-cap stocks and take advantage of the prevalent arbitrage opportunities in the market by concentrating on these money-making small-cap stocks.

Clovis’ largest equity holding, in Colony Capital Inc (NYSE:CLNY), was comprised of some 1.27 million shares valued at $32.94 million. The fund acquired an additional 1,000 shares of the $2.87 billion real estate investment and finance company during the first quarter. Colony Capital Inc (NYSE:CLNY) has been in Clovis’ portfolio since the third quarter of 2012. The fund also holds a call position valued at $15.55 million on 600,000 underlying shares of Colony Capital Inc (NYSE:CLNY). The REIT failed to impress investors with its financial results for the first quarter, which included Funds From Operations of $0.49, coming in $0.01 below expectations and revenues of $116.61 million that were also $3.32 million short of estimates. Colony Capital Inc (NYSE:CLNY) is also found in the equity portfolios of John Brennan‘s Sirios Capital Management and Brian Jackelow‘s SAB Capital Management.

Next in line is Churchill Downs, Inc. (NASDAQ:CHDN), in which Clovis’ stake was increased by a whopping 82% to 250,000 shares valued at $28.74 million. The holding represented about 8.08% of the fund’s portfolio value. The diversified company operates in three segments: racing operations consisting of five racetracks, gaming operations in six properties boasting of a total of 4,200 slots, 55 tables, 36 poker tables, 185 hotel rooms, and 775 video poker machines, and lastly online operations including an internet wagering business. Churchill Downs, Inc. (NASDAQ:CHDN) has appreciated by a hefty 28.02% year-to-date. Another prominent shareholder of the company is Paul Reeder and Edward Shapiro’s PAR Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!